CClinicalTrials.gg
Status unknownNCT03504332Updated Apr 20, 2018

Revascularization of Immature Anterior Necrotic Teeth

A Phase 3 interventional study of intracanal disinfection in revascularization in Pulp Necroses, sponsored by Cairo University. Status unknown. Open to participants aged 7 Years to 15 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-04-20.

Sponsored by Cairo University · Phase 3, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2018), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Phase 3
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
7 Years to 15 Years
Sex
All
01

Study summary

The object of this study is to compare the effect of Calcium Hydroxide and Di-antibiotic paste as intracanal disinfectants in the 1st visit of revascularization of necrotic immature permanent anterior teeth.

Read the detailed description

Dental trauma is common in children and it is the main cause of loss of pulp vitality in immature permanent anterior teeth with prevalence rate of 11% and about of 27% of traumatized anterior teeth are left untreated.

Dentists face many challenges during the treatment of infected immature permanent teeth. This is mainly due to the thin dentinal walls of the root and blunderbuss apices that make these teeth susceptible to fracture during and after treatment.

Traditionally, Calcium Hydroxide apexification has been the only method for managing these cases.. however, it was found that this technique caused additional reduction in root strength due to the long-term application of Calcium Hydroxide which may end in fracture of the tooth. The time needed for complete apexification using Calcium Hydroxide was reported to be variable ranging from 5 to 20 months, with failure rate 0f 30% . Therefore, this technique is no longer recommended for the treatment of such cases.

A recently proposed technique for the treatment of immature necrotic permanent teeth is revascularization regenerative endodontic therapy (RET). It is a biologically based technique that allow the continuation of root development and thickening of dentinal walls. This is achieved through proper disinfection o the root canal system, creation of scaffold and perfect coronal seal.

For proper disinfection of the root canal system, antibiotic paste was applied as intracanal dressing for 2-3 weeks. However, the recent recommendations by the European society of Endodontology advices the use of Calcium Hydroxide as intracanal medication instead of intracanal antibiotics. This is because of some concerns regarding the use of antibiotics which include: cytotoxicity to stem cells needed for the revascularization process, risk of antibiotic resistance and the risk of sensitization. Calcium Hydroxide on the other hand is widely used as intracanal disinfectant and some studies were found supporting its use in the revascularization technique, [9, 10]. However, the data available is not sufficient regarding the effectiveness of Calcium Hydroxide in revascularization of necrotic pulp.

Besides, more trials are needed to evaluate the clinical effectiveness of RET in management of immature necrotic permanent teeth as the evidence of using this technique is still weak.

02

Conditions studied

  • Pulp Necroses

Keywords

  • immature teeth, revascularization
03

In context

Dental Pulp Necrosis

149 studies on the registry are indexed under Dental Pulp Necrosis; 39 are open to participants now.

This study's planned enrollment of 56 is above the median of 44 across 139 interventional studies indexed under Dental Pulp Necrosis.

Browse Dental Pulp Necrosis studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Immature anterior teeth with open apices.
  • Necrotic teeth (regardless the cause of pulpal involvement: Caries, trauma or congenital anomalies).
  • Children free from any systemic diseases that may interfere with the normal healing process.

Exclusion criteria

Exclusion Criteria:

  • Children Allergic to antibiotics to be used in the study.
  • unooperative children.
  • Laxative injuries.
  • Compromised remaining tooth structure.
  • internal or external root resorption
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
56 participants (estimated)

Study arms

  • Experimental
    Calcium Hydroxide in revascularization

    Revascularization of necrotic anterior teeth: canals disinfection step. Pure Calcium Hydroxide powder mixed with saline will be placed as intra-canal medication in the 1st visit of dental pulp revascularization.

    Procedure: intracanal disinfection in revascularization

  • Active comparator
    Di-antibiotic paste in revascularization

    Revascularization of necrotic anterior teeth: canals disinfection step. Mix 1:1 ciprofloxacin: metronidazole to a final concentration of 0.1 mg/ml, placed as intra-canal medication in the 1st visit of dental pulp revascularization.

    Procedure: intracanal disinfection in revascularization

Interventions

  • Procedureintracanal disinfection in revascularization

    a procedure to create vital cells in the pulp space of immature teeth which enables thickening of the dentinal walls of the root.

06

What researchers measure

Primary outcomes

  1. Pain

    Binary outcome (present/ absent). Assessed by asking the patient

    Time frame: baseline.

  2. Change in pain

    Binary outcome (present/ absent). Assessed by asking the patient.

    Time frame: at 6 and 12 months

Secondary outcomes

  1. Pain on percussion

    Binary outcome (present/absent).Assessed by using back of the dental mirror.

    Time frame: baseline and for 1 year follow up

  2. Swelling

    Binary outcome (present/absent). Assessed by visual inspection of labial vestibules.

    Time frame: baseline and for 1 year follow up

  3. Sinus or fistula

    Binary outcome (present/absent). Assessed by visual inspection of labial vestibules.

    Time frame: baseline and for 1 year follow up

  4. Root Lengthening

    Will be evaluated radiographically using DIGORA software. Unit of measurement will be mm.

    Time frame: baseline and for 1 year follow up

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 20, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03504332
Lead sponsor
Cairo University
Responsible party
Reem Mohamed Fouad Wahby (Principal Investigator, Cairo University) — Principal investigator
First posted
Apr 20, 2018
Start date
Jun 2018 (estimated)
Primary completion
Jun 2020 (estimated)
Completion
Sep 2020 (estimated)
Last update
Apr 20, 2018

Study contacts

Reem Wahby, MD
Contact
reem.wahby@dentistry.cu.edu.eg
0020112652778

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion